Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways

Abstract Background Non-canonical Wnt pathways play important roles in liver fibrosis. Notum is a newly discovered inhibitor to Wnt proteins. This study was to investigate anti-fibrotic effects of Notum. Methods 53 patients with hepatitis B virus (HBV) infection as well as a cell co-culture system o...

Full description

Bibliographic Details
Main Authors: Wenting Li, Xiaolan Yu, Chuanlong Zhu, Zheng Wang, Zonghao Zhao, Yi Li, Yonghong Zhang
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Biological Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40659-019-0217-8
_version_ 1818851845743837184
author Wenting Li
Xiaolan Yu
Chuanlong Zhu
Zheng Wang
Zonghao Zhao
Yi Li
Yonghong Zhang
author_facet Wenting Li
Xiaolan Yu
Chuanlong Zhu
Zheng Wang
Zonghao Zhao
Yi Li
Yonghong Zhang
author_sort Wenting Li
collection DOAJ
description Abstract Background Non-canonical Wnt pathways play important roles in liver fibrosis. Notum is a newly discovered inhibitor to Wnt proteins. This study was to investigate anti-fibrotic effects of Notum. Methods 53 patients with hepatitis B virus (HBV) infection as well as a cell co-culture system of LX-2 and Hep AD38 cells were engaged in this study. Clinical, biological and virological data of each patient were analyzed. Cell viability was detected at different time points. mRNA and protein levels of NFATc1 (Nuclear factor of activated T-cells), Jnk, α-SMA, Col1A1 and TIMP-1 were detected both in LX-2 and liver tissue. Protein levels of NFATc1 and Jnk in liver tissue and their correlations with fibrosis score were analyzed. Results Hepatitis B virus replication up-regulated Wnt5a induced NFATc1 and Jnk activity in Hep AD38. Notum suppressed NFATc1, Jnk and fibrosis genes expression, reduced cell viability in co-cultured LX-2 cells induced by HBV. Interestingly, Patients with HBV DNA > 5log copies/ml had higher mRNA levels of NFATc1 and fibrosis genes than patients with HBV DNA < 5log copies/ml. Most importantly, protein expressions of NFATc1 and pJnk have positive correlations with liver fibrosis scores in HBV-infected patients. Conclusions Our data showed that Notum inhibited HBV-induced liver fibrosis through down-regulating Wnt 5a mediated non-canonical pathways. This study shed light on anti-fibrotic treatment.
first_indexed 2024-12-19T07:11:30Z
format Article
id doaj.art-ac9fe6e1e3f542db92420e79774e630c
institution Directory Open Access Journal
issn 0717-6287
language English
last_indexed 2024-12-19T07:11:30Z
publishDate 2019-03-01
publisher BMC
record_format Article
series Biological Research
spelling doaj.art-ac9fe6e1e3f542db92420e79774e630c2022-12-21T20:31:12ZengBMCBiological Research0717-62872019-03-0152111110.1186/s40659-019-0217-8Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathwaysWenting Li0Xiaolan Yu1Chuanlong Zhu2Zheng Wang3Zonghao Zhao4Yi Li5Yonghong Zhang63rd Liver Unit, Department of Infectious Disease, Anhui Provincial HospitalDepartment of Ear-Nose-Throat, Anhui Provincial Hospital, Anhui Medical UniversityDepartment of Infectious Disease, The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Respiratory and Critical Medicine, People’s Hospital of Zhengzhou University3rd Liver Unit, Department of Infectious Disease, Anhui Provincial Hospital3rd Liver Unit, Department of Infectious Disease, Anhui Provincial HospitalDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityAbstract Background Non-canonical Wnt pathways play important roles in liver fibrosis. Notum is a newly discovered inhibitor to Wnt proteins. This study was to investigate anti-fibrotic effects of Notum. Methods 53 patients with hepatitis B virus (HBV) infection as well as a cell co-culture system of LX-2 and Hep AD38 cells were engaged in this study. Clinical, biological and virological data of each patient were analyzed. Cell viability was detected at different time points. mRNA and protein levels of NFATc1 (Nuclear factor of activated T-cells), Jnk, α-SMA, Col1A1 and TIMP-1 were detected both in LX-2 and liver tissue. Protein levels of NFATc1 and Jnk in liver tissue and their correlations with fibrosis score were analyzed. Results Hepatitis B virus replication up-regulated Wnt5a induced NFATc1 and Jnk activity in Hep AD38. Notum suppressed NFATc1, Jnk and fibrosis genes expression, reduced cell viability in co-cultured LX-2 cells induced by HBV. Interestingly, Patients with HBV DNA > 5log copies/ml had higher mRNA levels of NFATc1 and fibrosis genes than patients with HBV DNA < 5log copies/ml. Most importantly, protein expressions of NFATc1 and pJnk have positive correlations with liver fibrosis scores in HBV-infected patients. Conclusions Our data showed that Notum inhibited HBV-induced liver fibrosis through down-regulating Wnt 5a mediated non-canonical pathways. This study shed light on anti-fibrotic treatment.http://link.springer.com/article/10.1186/s40659-019-0217-8NotumWnt signaling pathwayHBVLiver fibrosis
spellingShingle Wenting Li
Xiaolan Yu
Chuanlong Zhu
Zheng Wang
Zonghao Zhao
Yi Li
Yonghong Zhang
Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
Biological Research
Notum
Wnt signaling pathway
HBV
Liver fibrosis
title Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_full Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_fullStr Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_full_unstemmed Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_short Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
title_sort notum attenuates hbv related liver fibrosis through inhibiting wnt 5a mediated non canonical pathways
topic Notum
Wnt signaling pathway
HBV
Liver fibrosis
url http://link.springer.com/article/10.1186/s40659-019-0217-8
work_keys_str_mv AT wentingli notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT xiaolanyu notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT chuanlongzhu notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT zhengwang notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT zonghaozhao notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT yili notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways
AT yonghongzhang notumattenuateshbvrelatedliverfibrosisthroughinhibitingwnt5amediatednoncanonicalpathways